endocrine pharm Flashcards
D2 receptor agonists and job
cabergoline
bromocriptine
inhibit prolactin
somatostatin analogs
otreotide
pasireotide
GH receptor antagonist
pegvisomant
Hyperpituitarism results in increased secretion of pituitary hormones, often caused by a _______
pituitary adenoma
growth hormone releasing hormone
somatocrinin
growth hormone release inhibiting hormone
somatostatin
Hypopituitarism results in reduced secretion of various hormones, and is treated by replacing them with ____________
natural or synthetic analogs
mineralocorticoids like ______, replacement is used for defect in the ____
fludrocortisone, used in primary adrenal defect
glucocorticoid antagonists
mifepristone, spironolactone
glucocorticoid synthesis inhibitors
ketoconazole, aminoglutehimide
primary adrenal insufficiency pathologies
adrenal destruction (autoimmune), adrenal dysgenesis (genetic), cortisol synthesis defects (genetic)
hypocortisolism results in
hypoglycemia, hypercalcemia and anemia, high ACTH/MSG, pigmentation
____ leads to hyponatremia, hyperkalemia, and water loss
hypoaldosteronism
Addisons disease is treated with
replacement steroid hormones
gerneralized symptoms of hypercortisolism
weight gain, slow healing of cuts, increased risk of infections, fatigue, glucose intolerance, headache, moonfaced, buffalo hump, hirsutism, striae
Pasireotide: MoA
Inhibits the release of GH from corticotrophic cells in the pituitary gland
Ketoconazole & aminoglutethimide: MoA
Inhibit the synthesis of cortisol
ketoconazole has _____ effects in men such as
anti-androgenic such as decreased libido and impotence
ketoconazole has drug interactions due to inhibition of
CYP3A4
Mifepristone & spironolactone: MoA
Competitively inhibit cortisol binding to the GC receptor
spironolactone toxicity
hyperkalemia
Conn syndrome
primary hyperaldosteronism
bisphosphonates
alendronate, risedronate, ibandronate, zoledronate
Bisphosphonates: MoA
Bind to bone and cause osteoclasts to die (apoptosis)